-
121por Petruzziello, Arnolfo, Marigliano, Samantha, Loquercio, Giovanna, Cozzolino, Anna, Cacciapuoti, Carmela“…AIM: To review Hepatitis C virus (HCV) prevalence and genotypes distribution worldwide. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
122por van Buuren, Nicholas, Fradette, Lorraine, Grebely, Jason, King, Alexandra, Krajden, Mel, MacParland, Sonya A., Marshall, Alison, Saeed, Sahar, Wilson, Joyce, Klein, Marina B., Sagan, Selena M.“…Hepatitis C virus (HCV) affects approximately 268,000 Canadians and results in more years of life lost than any other infectious disease in the country. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
123
-
124por Samuel, Sandeep T, Martinez, Anthony D, Chen, Yang, Markatou, Marianthi, Talal, Andrew H“…AIM: To understand the role of knowledge as a promoter of hepatitis C virus (HCV) screening among primary care physicians (PCP). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
125por Hooshmand, Behzad, Alavian, Seyed Moayed, Kouhestani, Farnaz, Firouzmandi, Maryam, Motamedian, Saeed Reza“…BACKGROUND: The aim of the current study was to detect hepatitis C virus (HCV) RNA in blood and saliva of a population of patients with thalassemia who have HCV antibody in their serum. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
126por Le Ngoc, Chau, Tran Thi Thanh, Thanh, Tran Thi Lan, Phuong, Nguyen Mai, Trinh, Nguyen Hoa, Trang, Nghiem My, Ngoc, Le Van, Tan, Le Manh, Hung, Le Thanh, Phuong, Nguyen Van Vinh, Chau, Thwaites, Guy, Cooke, Graham, Heilek, Gabrielle M., Shikuma, Cecilia, Le, Thuy, Baker, Stephen, Rahman, Motiur“…BACKGROUND: The highest burden of disease from hepatitis C virus (HCV) is found in Southeast Asia, but our understanding of the epidemiology of infection in many heavily burdened countries is still limited. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
127por Kronfli, Nadine, Bhatnagar, Sahir R., Hull, Mark W., Moodie, Erica E.M., Cox, Joseph, Walmsley, Sharon, Gill, John, Cooper, Curtis, Martel-Laferrière, Valérie, Pick, Neora, Klein, Marina B.“…OBJECTIVE: Hepatitis C virus (HCV) treatment may reduce liver-related mortality but with competing risks, other causes of mortality may undermine benefits. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
128“…The study aimed to investigate whether the glucose level improves and what factors affect the improvement in glucose control after the eradication of hepatitis C virus (HCV). A total of 1090 patients with HCV infections were enrolled, among which 278 (25.5%) patients were diagnosed with prediabetes, and 89 (8.16%) patients were diagnosed with diabetes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
129
-
130por Viera, Adam, Grau, Lauretta E., Fisher, Jeffrey D., Farnum, Scott O., Tetrault, Jeanette M., Scott, Greg, Heimer, RobertEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
131por Antoniou, Tony, Pritlove, Cheryl, Shearer, Dana, Tadrous, Mina, Shah, Hemant, Gomes, TaraEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
132por Caraballo Cortés, Kamila, Osuch, Sylwia, Perlejewski, Karol, Radkowski, Marek, Janiak, Maciej, Berak, Hanna, Rauch, Andri, Fehr, Jan S, Hoffmann, Matthias, Günthard, Huldrych F, Metzner, Karin J“…We assessed 2 iRs—PD-1 (programmed cell death protein 1) and Tim-3 (T-cell immunoglobulin and mucin domain–containing protein 3)—and IL-10 mRNAs in peripheral blood mononuclear cells (PBMCs) and their soluble analogs (sPD-1, sTim-3, and IL-10) in plasma in chronic HIV-1/hepatitis C virus (HCV) coinfection and explored the effect of HCV treatment on these markers. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
133por Maylin, Sarah, Martinot-Peignoux, Michelle, Ripault, Marie-Pierre, Moucari, Rami, Cardoso, Ana Carolina, Boyer, Nathalie, Giuily, Nathalie, Castelnau, Corinne, Pouteau, Michelle, Asselah, Tarik, Nicolas-Chanoine, Marie Hélène, Marcellin, Patrick“…BACKGROUND/AIM: Viral eradication in chronic hepatitis C patients with sustained virological response (SVR) after interferon (IFN) therapy remains controversial. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
134por El-Kamary, Samer S., Hashem, Mohamed, Saleh, Doaa A., Abdelwahab, Sayed F., Sobhy, Maha, Shebl, Fatma M., Shardell, Michelle D., Strickland, G. Thomas, Shata, Mohamed Tarek“…OBJECTIVE: To investigate the association between hepatitis C virus (HCV)-specific cell-mediated immunity (CMI) responses and viral clearance in children born to mothers infected with HCV. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
135por Chew, Kara W., Hua, Lei, Bhattacharya, Debika, Butt, Adeel A., Bornfleth, Lorelei, Chung, Raymond T., Andersen, Janet W., Currier, Judith S.“…BACKGROUND: Successful hepatitis C virus (HCV) treatment may reduce cardiovascular disease (CVD) risk and improve levels of CVD biomarkers produced outside the liver (nonhepatic biomarkers). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
136por Fierro, Nora A, González-Aldaco, Karina, Torres-Valadez, Rafael, Trujillo-Trujillo, Maria E, Roman, Sonia, Trujillo-Ochoa, Jorge L, Panduro, Arturo“…The mechanisms related to the spontaneous clearance of hepatitis C virus (HCV) have been primarily studied in regions where the infection is endemic. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
137por Tachi, Yoshihiko, Hirai, Takanori, Toyoda, Hidenori, Tada, Toshifumi, Hayashi, Kazuhiko, Honda, Takashi, Ishigami, Masatoshi, Goto, Hidemi, Kumada, Takashi“…Liver fibrosis remains an important risk factor for hepatocarcinogenesis in patients with chronic hepatitis C even after the eradication of hepatitis C virus (HCV). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
138por O’Neil, Conar R, Pang, Jack XQ, Lee, Samuel S, Swain, Mark G, Burak, Kelly W, Klein, Patricia, Myers, Robert P, Kapler, Jeff, Gill, Michael J, Labrie, Martin, Coffin, Carla SEnlace del recurso
Publicado 2015
Enlace del recurso
Online Artículo Texto -
139“…BACKGROUND: Hepatitis C infection is a global public health issue. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
140por Rivero-Juarez, A., Lopez-Cortes, L. F., Castaño, M., Merino, D., Marquez, M., Mancebo, M., Cuenca-Lopez, F., Jimenez-Aguilar, P., Lopez-Montesinos, I., Lopez-Cardenas, S., Collado, A., Lopez-Ruz, M. A., Omar, M., Tellez, F., Perez-Stachowski, X., Hernandez-Quero, J., Girón-Gonzalez, J. A., Fernandez-Fuertes, E., Rivero, A.“…In April 2015, the Spanish National Health System (SNHS) developed a national strategic plan for the diagnosis, treatment, and management of hepatitis C virus (HCV). Our aim was to analyze the impact of this on human immunodeficiency virus (HIV)-infected patients included in the HERACLES cohort during the first 6 months of its implementation. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto